(CercleFinance.com) – Onxeo announces that its Combined General Meeting has adopted all the resolutions presented by its Board of Directors, including the withdrawal of the shares from listing on the Nasdaq First North market in Copenhagen.
The shareholders have given all powers to the board of directors to carry out this withdrawal, and the biotechnology company will therefore formally request it, in the coming days, from the Danish stock market operator.
After approval of the latter, the effective withdrawal of Nasdaq First North should take place after an additional period of 10 weeks. Onxeo is considering an automatic exchange of securities for its Danish shareholders to be able to trade their shares on Euronext Growth.